Adaptive Immunomodulation-Based Therapeutics
Abstract
The Adaptive Immunomodulation-Based Therapeutics program will develop platform technologies to interrogate and define the biological pathways that modulate the immune response and critical organ function. One approach to achieve this capability will require the development of new tools to stimulate and measure responses of the nervous system in order to map the bioelectric code modulates. This program will also identify immune function correlates for health and early detection of disease. An additional approach involves characterizing the host response in patients with severe infections, and developing a quantitative framework that can be used to guide modulation of the immune response. Algorithms will be developed to evaluate and predict various physiological conditions within an individual. Advances made under the Adaptive Immunomodulation-Based Therapeutics program will improve our response capability against severe infectious diseases and biological threats and offer new avenues for treating disease or organ function.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2017
- Source ID
- a9aecae0d60b196550c9c04cace02707